TrademarkDir
VERTEX CELL AND GENETIC THERAPIES
DEAD

Serial Number

88832541

Owner

VERTEX PHARMACEUTICALS INCORPORATED

Attorney

Steven A. Abreu

Filing Date

Mar 12, 2020

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

VERTEX CELL AND GENETIC THERAPIES Trademark

Serial Number: 88832541

VERTEX CELL AND GENETIC THERAPIES is a trademark filed by VERTEX PHARMACEUTICALS INCORPORATED on March 12, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

VERTEX PHARMACEUTICALS INCORPORATED (191 trademarks)

Boston, MA 02210

Entity Type: 03

Trademark Details

Filing Date

March 12, 2020

Registration Date

Not Registered

Published for Opposition

July 28, 2020

Goods & Services

house mark for pharmaceutical preparations; nucleic acid medicines for the treatment of genetic diseases and disorders; pharmaceutical preparations for the treatment of genetic diseases and disorders; pharmaceutical preparations for the treatment of muscular dystrophy

medical and scientific research in the field of gene therapy; medical and scientific research in the field of nucleic acid; medical and scientific research in the field of gene editing for developing cells and pharmaceuticals for medical and clinical use; research and development of pharmaceuticals using gene editing

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 23, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 23, 2023 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 8, 2023 EXRA
SOU EXTENSION 5 GRANTED
Mar 7, 2023 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 7, 2023 AITU
SOU EXTENSION 5 FILED
Feb 22, 2023 EXT5
SOU TEAS EXTENSION RECEIVED
Feb 22, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 28, 2022 EXRA
SOU EXTENSION 4 GRANTED
Jul 26, 2022 EX4G
SOU EXTENSION 4 FILED
Jul 26, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Jul 26, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 18, 2022 EXRA
SOU EXTENSION 3 GRANTED
Feb 16, 2022 EX3G
SOU EXTENSION 3 FILED
Feb 16, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Feb 16, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 20, 2021 EXRA
SOU EXTENSION 2 GRANTED
Aug 18, 2021 EX2G
SOU EXTENSION 2 FILED
Aug 18, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 18, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 23, 2021 EXRA
SOU EXTENSION 1 GRANTED
Jan 21, 2021 EX1G
SOU EXTENSION 1 FILED
Jan 21, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 21, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 22, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 28, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jul 28, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 8, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 21, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 17, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 17, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 17, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 7, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jun 7, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jun 7, 2020 CNRT
ASSIGNED TO EXAMINER
Jun 3, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 18, 2020 NWOS
NEW APPLICATION ENTERED
Mar 16, 2020 NWAP

Related Trademarks

More from this Owner

POWER FORWARD

POWER FORWARD

POWER FORWARD

POWER FORWARD

POWER FORWARD

POWER FORWARD

WHERE PAIN STARTS JOURNAVX BEGINS

WHERE PAIN STARTS JOURNAVX BEGINS

WHERE PAIN STARTS JOURNAVX BEGINS

WHERE PAIN STARTS JOURNAVX BEGINS

WHERE PAIN STARTS JOURNAVX BEGINS

WHERE PAIN STARTS JOURNAVX BEGINS